Associated Papers
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM5_ESM.xlsx › ANKL2
A novel mutation in nuclear prelamin a recognition factor-like causes diffuse pulmonary arteriovenous malformations.
Liu HZ et al.
Oncotarget, 2017
27835862 (PubMed )
Supplement: oncotarget-08-2708-s002.xls › candidate
Select a paper to view details